”How are we doing? It’s tough”
Times are hard, announced a leading US biotech-player during a grandiose stage performance in Boston last week. But the dark clouds have a silver lining, and the conference presented other encouraging news and conclusions. Here is the state of the biotech world, locally and globally, courtesy of Medwatch’s man in the field.
Boston, USA
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
